(Meredith) – A major pharmaceutical company is recalling its blood pressure medication after detecting trace amounts of an ingredient that may cause cancer.
The Food and Drug Administration is alerting consumers to a voluntary recall of Iosartan potassium/hydrochlorithiazide 100mg/25mg combination tablets manufactured by Macleods Pharmaceuticals. The recall is due to unacceptable amounts of N-nitrosodiethylamine (NDEA), which the FDA describes as "a substance that occurs naturally in foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen."
To date, there have been no reports of adverse reactions related to this recall.
This is the latest in a long string of recalls related to N-nitrosodiethylamine contamination in recent months. A full list of the recalled products, and their labels, can be found on the FDA's website. Expiration dates range from May 2019 to March 2021.
Patients who are prescribed the medication should continue taking it, but are also advised to contact a pharmacist or doctor to find an alternative treatment. The FDA says "the risk of harm to the patient’s health may be higher if the treatment is stopped immediately" without a suitable substitute.